A Randomized Phase 2 Study of Erlotinib Alone and in Combination with Bortezomib in Previously Treated Advanced Non-small Cell Lung Cancer

Thomas J. Lynch; David Fenton; Vera Hirsh; David Bodkin; Edward L. Middleman; Alberto Chiappori; Balazs Halmos; Reyna Favis; Hua Liu; William L. Trepicchio; Omar Eton; Frances A. Shepherd

doi:10.1097/jto.0b013e3181aba89f

A Randomized Phase 2 Study of Erlotinib Alone and in Combination with Bortezomib in Previously Treated Advanced Non-small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3181aba89f ◽

2009 ◽

Vol 4 (8) ◽

pp. 1002-1009 ◽

Cited By ~ 39

Author(s):

Thomas J. Lynch ◽

David Fenton ◽

Vera Hirsh ◽

David Bodkin ◽

Edward L. Middleman ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Phase 2 Study ◽

Previously Treated ◽

Randomized Phase 2

Download Full-text

P2.01-19 Phase 2 Study of Telisotuzumab Vedotin (Teliso-V) in Previously Treated c-MET+ Non-Small Cell Lung Cancer: Trial in Progress

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.1363 ◽

2019 ◽

Vol 14 (10) ◽

pp. S646 ◽

Cited By ~ 1

Author(s):

C. Ocampo ◽

J. Wu ◽

J. Dey ◽

Z. Sun ◽

M. Motwani ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Cancer Trial ◽

Phase 2 Study ◽

Previously Treated

Download Full-text

A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.07.2260 ◽

2015 ◽

Vol 93 (4) ◽

pp. 757-764 ◽

Cited By ~ 155

Author(s):

Gregory M.M. Videtic ◽

Chen Hu ◽

Anurag K. Singh ◽

Joe Y. Chang ◽

William Parker ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Stereotactic Body Radiation Therapy ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text

Final Results of a Randomized Phase 2 Study Comparing Carboplatin Plus Irinotecan (Ci) Versus Carboplatin Plus Amrubicin (Ca) for Extensive Disease Small-Cell Lung Cancer: Njlcg0901

Annals of Oncology ◽

10.1093/annonc/mdu355.14 ◽

2014 ◽

Vol 25 ◽

pp. iv515

Author(s):

Y. Tsukita ◽

N. Morikawa ◽

S. Sugawara ◽

M. Maemondo ◽

T. Harada ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Extensive Disease ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text

Bortezomib ± docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC): A phase 2 study

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7034 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7034-7034 ◽

Cited By ~ 23

Author(s):

M. P. Fanucchi ◽

F. Fossella ◽

P. Fidias ◽

R. B. Natale ◽

R. J. Belt ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Phase 2 Study ◽

Previously Treated Patients ◽

Previously Treated

Download Full-text

A randomized phase 2 study of abemaciclib versus docetaxel in patients with stage IV squamous non-small cell lung cancer (sqNSCLC) previously treated with platinum-based chemotherapy.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.9059 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 9059-9059

Author(s):

Giorgio V. Scagliotti ◽

Igor Bondarenko ◽

Tudor-Eliade Ciuleanu ◽

Maciej Bryl ◽

Andrea Fülöp ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Stage Iv ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Platinum Based Chemotherapy ◽

Phase 2 Study ◽

Previously Treated ◽

Randomized Phase 2

Download Full-text

Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non–Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2017.11.131 ◽

2018 ◽

Vol 13 (4) ◽

pp. 576-584 ◽

Cited By ~ 29

Author(s):

Enriqueta Felip ◽

Fabrice Barlesi ◽

Benjamin Besse ◽

Quincy Chu ◽

Leena Gandhi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Phase 2 Study ◽

Previously Treated ◽

Hsp 90

Download Full-text

Comment on ‘Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer’—No support for de-escalation of immunotherapy

European Journal of Cancer ◽

10.1016/j.ejca.2019.04.011 ◽

2019 ◽

Vol 115 ◽

pp. 24-26

Author(s):

Alexandros Georgiou ◽

Anna Minchom ◽

Mary O'Brien

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Phase 2 Study ◽

Previously Treated

Download Full-text

Randomized phase 2 study of carboplatin plus irinotecan (CI) versus carboplatin plus amrubicin (CA) for extensive disease small-cell lung cancer (ED-SCLC): NJLCG0901.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.7521 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 7521-7521

Author(s):

Yosuke Kawashima ◽

Naoto Morikawa ◽

Shunichi Sugawara ◽

Makoto Maemondo ◽

Toshiyuki Harada ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Extensive Disease ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text

P47.02 EV-202: Phase 2 Study of Enfortumab Vedotin for Previously Treated Advanced Solid Tumors Including Non-Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.08.495 ◽

2021 ◽

Vol 16 (10) ◽

pp. S1096-S1097

Author(s):

K. Muro ◽

J. Yang Bruce ◽

J. Baranda ◽

T. Feinstein ◽

X. Li ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Solid Tumors ◽

Cell Lung Cancer ◽

Small Cell ◽

Advanced Solid Tumors ◽

Phase 2 ◽

Small Cell Lung ◽

Phase 2 Study ◽

Previously Treated

Download Full-text

ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin‐bound paclitaxel with or without CC‐486 as second‐line treatment for advanced nonsquamous non‐small cell lung cancer (NSCLC)

Cancer ◽

10.1002/cncr.31779 ◽

2018 ◽

Vol 124 (24) ◽

pp. 4667-4675 ◽

Cited By ~ 3

Author(s):

Daniel Morgensztern ◽

Manuel Cobo ◽

Santiago Ponce Aix ◽

Pieter E. Postmus ◽

Conrad R. Lewanski ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Second Line ◽

Phase 2 ◽

Small Cell Lung ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text